Phase I

embryonic stem cells
Biotech

Vor Bio's dual stem cell, ADC shows consistent engraftment

Vor Bio plans to accelerate enrollment of a phase 1/2 trial of its dual stem cell-ADC cancer therapy to get a fuller picture of post-relapse response.
Max Bayer Nov 9, 2023 4:10pm
photo of a number of hands in the center

Mediar gets a spark from Pfizer's Ignite program

Oct 25, 2023 10:50am
Money dollars bin drain loss failed

Alaunos winds down sole cell therapy trial, cuts 60% of staff

Aug 15, 2023 10:53am
A silver slightly shiny strands of DNA appear against a background of clocks

Beam aims to dose first patient in sickle cell trial this year

Aug 8, 2023 4:10pm
question unanswered wonder ask

Precision on the partnership prowl for lead asset after FDA chat

Jul 27, 2023 10:57am
Photo of a sunset over the horizon on a body of water

Viridian looks to beat Horizon's Tepezza in thyroid eye disease

Jul 10, 2023 4:01pm